HappyCross
Commercial- Indications
- Osteoarthritis
Company intelligence / Profile preview
LABRHA
Lyon, Auvergne-Rhône-Alpes, Francelabrha-international.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
LABRHA develops and markets natural products for the management of rheumatic diseases and musculoskeletal pain. The company collaborates with French rheumatologists to design its products and regularly conducts clinical trials to demonstrate efficacy and safety. Its portfolio includes viscosupplementation agents for osteoarthritis treatment. The company has an international presence through local distributors in over 30 countries planned by 2030.
- Therapeutic areas
- Rheumatology
- Modalities
- Natural productsviscosupplementation agents
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Eurovisco group partnership for annual board organization related to viscosupplementation in osteoarthritis since 2014
Beyond the preview
Go deeper on LABRHA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LABRHA.